A Study to Evaluate the Tolerability, Safety and Efficacy of VGM-R02b
Clinical trial NCT06217861 · RECRUITING
Trial details
- NCT number
- NCT06217861
- Sponsor
- Shanghai Vitalgen BioPharma Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-29
- Primary completion
- 2027-08-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.